BOK Financial Private Wealth’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-138
Closed -$15.5K 451
2025
Q1
$15.5K Buy
138
+137
+13,700% +$14.1K ﹤0.01% 361
2024
Q4
$93 Sell
1
-199
-100% -$17.9K ﹤0.01% 640
2024
Q3
$16.8K Hold
200
﹤0.01% 357
2024
Q2
$13.7K Hold
200
﹤0.01% 359
2024
Q1
$14.7K Hold
200
﹤0.01% 344
2023
Q4
$16.2K Buy
+200
New +$15.6K ﹤0.01% 332
2022
Q2
Sell
-3,643
Closed -$217K 402
2022
Q1
$217K Sell
3,643
-1,486
-29% -$95K 0.02% 288
2021
Q4
$372K Buy
5,129
+275
+6% +$18.9K 0.03% 201
2021
Q3
$339K Buy
4,854
+1,541
+47% +$108K 0.03% 182
2021
Q2
$228K Buy
+3,313
New +$221K 0.02% 206
2020
Q3
Sell
-2,752
Closed -$212K 165
2020
Q2
$212K Buy
2,752
+8
+0.3% +$613 0.02% 156
2020
Q1
$205K Buy
+2,744
New +$190K 0.02% 178

Other funds holding GILD

BOK Financial Private Wealth's GILD Position: Q2 2025 in Review

BOK Financial Private Wealth sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 138 shares — an estimated $15.5K sold.

BOK Financial Private Wealth first reported a position in GILD in Q1 2020 and held it in 12 quarters. The position peaked at $372K in Q4 2021. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • BOK Financial Private Wealth reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • BOK Financial Private Wealth sold 138 Gilead Sciences shares in Q2 2025, an estimated $15.5K.
  • BOK Financial Private Wealth first reported a position in Gilead Sciences in Q1 2020 and held it in 12 quarters.
  • BOK Financial Private Wealth's Gilead Sciences position peaked at $372K in Q4 2021.
  • 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on BOK Financial Private Wealth's 13F filing for Q2 2025, filed 7 Aug 2025.